Astellas US Holding

Iveric Bio Acquistion - JBIC Direct Loan

Borrower(s)
Astellas US Holding
Industry
Manufacturing & equipment/Pharmaceuticals
Area of finance
Export & Agency Finance
Region
North America
North America
Countries
United States

Deal Overview

The JBIC has signed a loan agreement with Astellas US Holding (AUSH) for up to $500 million which will be used to acquire Iveric Bio in a deal worth $5.9 billion. Iveric Bio specializes in developing treatments for retinal diseases, including geographic atrophy secondary to age-related macular...

show more
Deal Volume
$500m
Financial Close
05/09/2023
Dealmakers
Sources

Did you work on this deal?

This deal page needs more information from those involved.

Tag yourself TAG A COLLEAGUE SUGGEST AN EDIT

Tranches

To view all tranche and pricing information, login or upgrade to a subscription here